These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27116720)

  • 1. Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
    Singer BA
    Semin Neurol; 2016 Apr; 36(2):140-7. PubMed ID: 27116720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies for the treatment of multiple sclerosis].
    Sánchez-Seco VG; Casanova Peño I; Arroyo González R
    Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological treatment of multiple sclerosis].
    Sørensen PS; Sellebjerg F
    Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Agents for Relapsing Forms of Multiple Sclerosis.
    Straus Farber R; Harel A; Lublin F
    Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies in the treatment of multiple sclerosis.
    Di Pauli F; Berger T; Reindl M
    Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in treatment of multiple sclerosis.
    Rommer PS; Dudesek A; Stüve O; Zettl UK
    Clin Exp Immunol; 2014 Mar; 175(3):373-84. PubMed ID: 24001305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on disease-modifying treatments for multiple sclerosis.
    Carrithers MD
    Clin Ther; 2014 Dec; 36(12):1938-1945. PubMed ID: 25218310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New biological agents in the treatment of multiple sclerosis.
    Buc M
    Bratisl Lek Listy; 2018; 119(4):191-197. PubMed ID: 29663814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis.
    Trebst C; Voss E; Skripuletz T; Stangel M
    Curr Med Chem; 2010; 17(7):640-50. PubMed ID: 20088763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody treatments for multiple sclerosis.
    Rose JW; Foley J; Carlson N
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):419-26. PubMed ID: 18713579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment of multiple sclerosis].
    Gout O; Bensa C; Assouad R
    Rev Med Interne; 2010 Aug; 31(8):575-80. PubMed ID: 20579785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on disease-modifying therapies for multiple sclerosis.
    Vargas DL; Tyor WR
    J Investig Med; 2017 Jun; 65(5):883-891. PubMed ID: 28130412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in multiple sclerosis therapeutics.
    Spain RI; Cameron MH; Bourdette D
    BMC Med; 2009 Dec; 7():74. PubMed ID: 19968863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppression with monoclonal antibodies in multiple sclerosis].
    Vermersch P; Zéphir H
    Rev Neurol (Paris); 2007 Jun; 163(6-7):682-7. PubMed ID: 17607190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
    Chofflon M
    BioDrugs; 2005; 19(5):299-308. PubMed ID: 16207071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis.
    Xu X; Chi S; Wang Q; Li C; Xu B; Zhang J; Chen X
    Mult Scler Relat Disord; 2018 Oct; 25():322-328. PubMed ID: 30195200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating multiple sclerosis with natalizumab.
    Iaffaldano P; Lucchese G; Trojano M
    Expert Rev Neurother; 2011 Dec; 11(12):1683-92. PubMed ID: 22091593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daclizumab for the treatment of multiple sclerosis.
    Papadopoulou A; Derfuss T; Sprenger T
    Neurodegener Dis Manag; 2017 Oct; 7(5):279-297. PubMed ID: 28849702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.